Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenuePayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coya Therapeutics (COYA) Total Current Liabilities (2022 - 2025)

Historic Total Current Liabilities for Coya Therapeutics (COYA) over the last 4 years, with Q3 2025 value amounting to $3.7 million.

  • Coya Therapeutics' Total Current Liabilities rose 5813.05% to $3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year increase of 5813.05%. This contributed to the annual value of $3.8 million for FY2024, which is 2429.75% down from last year.
  • Coya Therapeutics' Total Current Liabilities amounted to $3.7 million in Q3 2025, which was up 5813.05% from $4.5 million recorded in Q2 2025.
  • Coya Therapeutics' Total Current Liabilities' 5-year high stood at $5.1 million during Q4 2023, with a 5-year trough of $1.2 million in Q2 2023.
  • In the last 4 years, Coya Therapeutics' Total Current Liabilities had a median value of $3.8 million in 2022 and averaged $3.3 million.
  • Over the last 5 years, Coya Therapeutics' Total Current Liabilities had its largest YoY gain of 24104.62% in 2024, and its largest YoY loss of 2429.75% in 2024.
  • Quarter analysis of 4 years shows Coya Therapeutics' Total Current Liabilities stood at $3.8 million in 2022, then surged by 32.13% to $5.1 million in 2023, then decreased by 24.3% to $3.8 million in 2024, then fell by 4.11% to $3.7 million in 2025.
  • Its Total Current Liabilities stands at $3.7 million for Q3 2025, versus $4.5 million for Q2 2025 and $4.3 million for Q1 2025.